Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study

[1]  L. Helyer,et al.  National consensus recommendations on patient-centered care for ductal carcinoma in situ , 2019, Breast Cancer Research and Treatment.

[2]  P. V. van Diest,et al.  Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands , 2018, Breast Cancer Research and Treatment.

[3]  L. Irwig,et al.  Carcinoma in situ of the breast in New South Wales, Australia: Current status and trends over the last 40 year. , 2018, Breast.

[4]  H. Hense,et al.  Detection Rates of Ductal Carcinoma in Situ with Biennial Digital Mammography Screening: Radiologic Findings Support Pathologic Model of Tumor Progression. , 2017, Radiology.

[5]  Donald L Weaver,et al.  The diagnostic challenge of low-grade ductal carcinoma in situ. , 2017, European journal of cancer.

[6]  Marien González-Lorenzo,et al.  Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review , 2016, International journal of cancer.

[7]  H. D. de Koning,et al.  The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening , 2016, Breast Cancer Research.

[8]  H. Hense,et al.  Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ? , 2016, Radiology.

[9]  Stephen W Duffy,et al.  Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study , 2016, The Lancet. Oncology.

[10]  L. Esserman,et al.  Rethinking the Standard for Ductal Carcinoma In Situ Treatment. , 2015, JAMA oncology.

[11]  W. Barry,et al.  Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study. , 2015, JAMA surgery.

[12]  D. Dodwell,et al.  Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  K. Kerlikowske,et al.  International variation in management of screen-detected ductal carcinoma in situ of the breast. , 2014, European journal of cancer.

[14]  H. Hense,et al.  Digital mammography screening: association between detection rate and nuclear grade of ductal carcinoma in situ. , 2014, Radiology.

[15]  K. Kerlikowske,et al.  Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network. , 2014, European journal of cancer.

[16]  G. Ball,et al.  The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS , 2012, British Journal of Cancer.

[17]  L. Esserman,et al.  Characterizing the impact of 25 years of DCIS treatment , 2011, Breast Cancer Research and Treatment.

[18]  K. Mokbel,et al.  Heterogeneity of ductal carcinoma in situ and its effects on management. , 2006, The Lancet. Oncology.

[19]  M. Silverstein,et al.  A prognostic index for ductal carcinoma in situ of the breast , 1996, Cancer.

[20]  M. J. van de Vijver,et al.  Ductal carcinoma in situ: a proposal for a new classification. , 1994, Seminars in diagnostic pathology.

[21]  J. Mandel,et al.  Screening in Chronic Disease , 1985 .

[22]  G. Hutchison,et al.  Prevalence, incidence and duration. , 1980, American journal of epidemiology.